136 related articles for article (PubMed ID: 8672755)
21. [Several histochemical changes in the mucous membrane of the duodenum in peptic ulcer (according to duodenal biopsy findings)].
Berlin LB; Uspenskiĭ VM
Arkh Patol; 1971 Oct; 33(10):69-74. PubMed ID: 4259068
[No Abstract] [Full Text] [Related]
22. [Specific IgE in the gastric and duodenal mucosa. An epiphenomenon or pathogenetic mechanism of some forms of "peptic" ulcer?].
De Lazzari F; Venturi C; Fregona I; Galliani EA; Bortolami M; Violato D; Floreani AR; Plebani M; Naccarato R
Minerva Gastroenterol Dietol; 1994 Mar; 40(1):1-9. PubMed ID: 8204699
[TBL] [Abstract][Full Text] [Related]
23. Impaired neutralizing capacity of duodenal mucosa following luminal acidification in recurrent duodenal ulcer.
Yokota H; Yanaka A; Muto H
Jpn J Med; 1991; 30(2):103-7. PubMed ID: 1865583
[TBL] [Abstract][Full Text] [Related]
24. Is gastric metaplasia essential for duodenal ulcer?
Amarapurkar DN; Parikh SS; Prabhu SR; Kalro RH; Desai HG
J Clin Gastroenterol; 1993 Oct; 17(3):204-6. PubMed ID: 8228080
[TBL] [Abstract][Full Text] [Related]
25. Duodenal mucosal architecture in non-specific and ulcer-associated duodenitis.
Hasan M; Sircus W; Ferguson A
Gut; 1981 Aug; 22(8):637-41. PubMed ID: 7286780
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin E2 and F2 alpha levels in the duodenal and antral mucosa of non-ulcer dyspeptic and duodenal ulcer patients.
Parodi MC; Marugo M; Ciancamerla G; Santucci R; Fazzuoli L
Hepatogastroenterology; 1990 Apr; 37(2):208-11. PubMed ID: 2341116
[TBL] [Abstract][Full Text] [Related]
27. [Ultrastructural aspects of active and healed duodenal ulcer].
Bode G; Malfertheiner P; Stanescu A; Mader U; Ditschuneit H
Z Gastroenterol; 1987 Aug; 25 Suppl 3():119-29. PubMed ID: 3660892
[TBL] [Abstract][Full Text] [Related]
28. Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: effects of aspirin and paracetamol.
Konturek SJ; Obtulowicz W; Sito E; Oleksy J; Wilkon S; Kiec-Dembinska A
Gut; 1981 Apr; 22(4):283-9. PubMed ID: 7239320
[TBL] [Abstract][Full Text] [Related]
29. Gastric metaplasia of the duodenum: identification by an endoscopic selective mucosal staining technique.
Mertz H; Kovacs T; Thronson M; Weinstein W
Gastrointest Endosc; 1998 Jul; 48(1):32-8. PubMed ID: 9684661
[TBL] [Abstract][Full Text] [Related]
30. Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs.
Taha AS; Dahill S; Nakshabendi I; Lee FD; Sturrock RD; Russell RI
Gut; 1993 Sep; 34(9):1162-6. PubMed ID: 8406146
[TBL] [Abstract][Full Text] [Related]
31. Gastric metaplasia in the duodenal bulb shows increased mucosal interleukin-8 activity in Helicobacter pylori-positive duodenal ulcer patients.
Noshiro M; Kusugami K; Sakai T; Imada A; Ando T; Ina K; Nobata K; Morise K; Kaneko H; Ito M; Nishio Y
Scand J Gastroenterol; 2000 May; 35(5):482-9. PubMed ID: 10868450
[TBL] [Abstract][Full Text] [Related]
32. Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum.
Savarino V; Mela GS; Zentilin P; Mele MR; Lapertosa L; Patetta R; Dallorto E; Vassallo A; Mansi C; Vigneri S; Celle G
Gut; 1996 Oct; 39(4):508-12. PubMed ID: 8944557
[TBL] [Abstract][Full Text] [Related]
33. The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist.
Pan S; Liao CH
Am J Gastroenterol; 1990 Aug; 85(8):949-52. PubMed ID: 1973870
[TBL] [Abstract][Full Text] [Related]
34. Gastric bicarbonate secretion and release of prostaglandin E2 are increased in duodenal ulcer patients but not in Helicobacter pylori-positive healthy subjects.
Mertz-Nielsen A; Hillingsø J; Frøkiaer H; Bukhave K; Rask-Madsen J
Scand J Gastroenterol; 1996 Jan; 31(1):38-43. PubMed ID: 8927938
[TBL] [Abstract][Full Text] [Related]
35. Mucosal cell proliferation in duodenal ulcer and duodenitis.
Bransom CJ; Boxer ME; Palmer KR; Clark JC; Underwood JC; Duthie HL
Gut; 1981 Apr; 22(4):277-82. PubMed ID: 7239319
[TBL] [Abstract][Full Text] [Related]
36. Decreased epithelial cytokine responses in the duodenal mucosa of Helicobacter pylori-infected duodenal ulcer patients.
Strömberg E; Edebo A; Svennerholm AM; Lindholm C
Clin Diagn Lab Immunol; 2003 Jan; 10(1):116-24. PubMed ID: 12522049
[TBL] [Abstract][Full Text] [Related]
37. Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients.
Vetvik K; Schrumpf E; Mowinckel P; Aase S; Andersen KJ
Scand J Gastroenterol; 1994 Nov; 29(11):995-1000. PubMed ID: 7871380
[TBL] [Abstract][Full Text] [Related]
38. The role of prostaglandin E2 in duodenal mucosa of healthy subjects and duodenal ulcer patients.
Basista M; Bednarz S; Rembiasz K; Grodzińska L; Kostka-Trabka E
Hepatogastroenterology; 1986 Dec; 33(6):271-4. PubMed ID: 3804186
[TBL] [Abstract][Full Text] [Related]
39. Distribution of prostaglandin E2 in gastric and duodenal mucosa: possible role in the pathogenesis of peptic ulcer.
Park SM; Yoo BC; Lee HR; Chung H; Lee YS
Korean J Intern Med; 1992 Jan; 7(1):1-8. PubMed ID: 1477025
[TBL] [Abstract][Full Text] [Related]
40. Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year's maintenance with cimetidine or sucralfate: a light and electron microscopy study.
Tovey FI; Husband EM; Yiu YC; Baker L; McPhail G; Lewin MR; Jayaraj AP; Clark CG
Gut; 1989 May; 30(5):586-93. PubMed ID: 2731750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]